<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>2019 European Alliance of Associations for Rheumatology (EULAR)/American College of Rheumatology (ACR) classification criteria for systemic lupus erythematosus</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">2019 European Alliance of Associations for Rheumatology (EULAR)/American College of Rheumatology (ACR) classification criteria for systemic lupus erythematosus</h1>
<div class="graphic"><div class="figure"><div class="ttl">2019 European Alliance of Associations for Rheumatology (EULAR)/American College of Rheumatology (ACR) classification criteria for systemic lupus erythematosus</div><div class="cntnt"><table cellspacing="0"><colgroup width="70%"></colgroup><colgroup width="30%"></colgroup> <tbody> <tr> <td class="subtitle1_left" colspan="2">The entry criterion is necessary to classify SLE.</td> </tr> <tr class="border_bottom_thick"> <td class="indent1" colspan="2"><strong>Entry criterion:</strong> <ul class="decimal_heading"> <li>ANA at a titer of ≥1:80 on HEp-2 cells or an equivalent positive test (ever).*</li> </ul> </td> </tr> <tr> <td class="subtitle1_left" colspan="2">At least 1 clinical criterion required to classify SLE. Additional additive (clinical or immunology) criteria are counted toward the total score.</td> </tr> <tr class="border_bottom_thick"> <td class="indent1" colspan="2"><strong>Additive criteria:</strong> <ul class="decimal_heading"> <li>Do not count a criterion if there is a more likely explanation than SLE.</li> <li>Occurrence of a criterion on ≥1 occasion is sufficient.</li> <li>Criteria need not occur simultaneously.</li> <li>Within each domain (eg, mucocutaneous, complement proteins), only the highest-weighted criterion is counted toward the total score if more than 1 is <span class="nowrap_whitespace">present.<sup>¶</sup></span></li> </ul> </td> </tr> <tr> <td class="subtitle1_left">Clinical domains and criteria</td> <td class="subtitle1">Weight</td> </tr> <tr> <td class="indent1" colspan="2"><strong>Constitutional</strong></td> </tr> <tr> <td class="indent2">Fever</td> <td class="centered">2</td> </tr> <tr class="highlight_lght_gray_text"> <td class="indent1" colspan="2"><strong>Hematologic</strong></td> </tr> <tr class="highlight_lght_gray_text"> <td class="indent2">Leukopenia</td> <td class="centered">3</td> </tr> <tr class="highlight_lght_gray_text"> <td class="indent2">Thrombocytopenia</td> <td class="centered">4</td> </tr> <tr class="highlight_lght_gray_text"> <td class="indent2">Autoimmune hemolysis</td> <td class="centered">4</td> </tr> <tr> <td class="indent1" colspan="2"><strong>Neuropsychiatric</strong></td> </tr> <tr> <td class="indent2">Delirium</td> <td class="centered">2</td> </tr> <tr> <td class="indent2">Psychosis</td> <td class="centered">3</td> </tr> <tr> <td class="indent2">Seizure</td> <td class="centered">5</td> </tr> <tr class="highlight_lght_gray_text"> <td class="indent1" colspan="2"><strong>Mucocutaneous</strong></td> </tr> <tr class="highlight_lght_gray_text"> <td class="indent2">Nonscarring alopecia</td> <td class="centered">2</td> </tr> <tr class="highlight_lght_gray_text"> <td class="indent2">Oral ulcers</td> <td class="centered">2</td> </tr> <tr class="highlight_lght_gray_text"> <td class="indent2">Subacute cutaneous or discoid lupus</td> <td class="centered">4</td> </tr> <tr class="highlight_lght_gray_text"> <td class="indent2">Acute cutaneous lupus</td> <td class="centered">6</td> </tr> <tr> <td class="indent1" colspan="2"><strong>Serosal</strong></td> </tr> <tr> <td class="indent2">Pleural or pericardial effusion</td> <td class="centered">5</td> </tr> <tr> <td class="indent2">Acute pericarditis</td> <td class="centered">6</td> </tr> <tr class="highlight_lght_gray_text"> <td class="indent1" colspan="2"><strong>Musculoskeletal</strong></td> </tr> <tr class="highlight_lght_gray_text"> <td class="indent2">Joint involvement</td> <td class="centered">6</td> </tr> <tr> <td class="indent1" colspan="2"><strong>Renal</strong></td> </tr> <tr> <td class="indent2">Proteinuria &gt;0.5 g per 24 hours</td> <td class="centered">4</td> </tr> <tr> <td class="indent2">Renal biopsy Class II or V lupus nephritis</td> <td class="centered">8</td> </tr> <tr class="border_bottom_thick"> <td class="indent2">Renal biopsy Class III or IV lupus nephritis</td> <td class="centered">10</td> </tr> <tr> <td class="subtitle1_left">Immunology domains and criteria</td> <td class="subtitle1">Weight</td> </tr> <tr> <td class="indent1" colspan="2"><strong>Antiphospholipid antibodies</strong></td> </tr> <tr> <td class="indent2">Anti-cardiolipin antibodies <strong>or</strong> anti-beta-2GP1 antibodies <strong>or</strong> lupus anticoagulant</td> <td class="centered">2</td> </tr> <tr class="highlight_lght_gray_text"> <td class="indent1" colspan="2"><strong>Complement proteins</strong></td> </tr> <tr class="highlight_lght_gray_text"> <td class="indent2">Low C3 <strong>or</strong> low C4</td> <td class="centered">3</td> </tr> <tr class="highlight_lght_gray_text"> <td class="indent2">Low C3 <strong>and</strong> low C4</td> <td class="centered">4</td> </tr> <tr> <td class="indent1" colspan="2"><strong>SLE-specific antibodies</strong></td> </tr> <tr class="border_bottom_thick"> <td class="indent2">Anti-dsDNA <span class="nowrap_whitespace">antibody<sup>Δ</sup></span> <strong>or</strong> anti-Smith antibody</td> <td class="centered">6</td> </tr> <tr> <td class="subtitle1_left" colspan="2">A total score of ≥10 and ≥1 clinical criterion are required to classify SLE.</td> </tr> <tr> <td class="indent1"><strong>Total score</strong></td> <td class="centered"><strong> </strong></td> </tr> </tbody></table></div><div class="graphic_footnotes"><p>SLE: systemic lupus erythematosus; ANA: antinuclear antibody; HEp-2: human epithelial type 2; anti-beta-2GP1: anti-beta-2 glycoprotein 1; anti-dsDNA: anti-double-stranded DNA.</p>
<p>* If ANA is absent, do <strong>not</strong> classify as SLE.</p>
<p>¶ Additional criteria within the same domain will not be counted.</p>
Δ In an assay with 90% specificity against relevant disease controls.</div><div class="graphic_reference">From: Aringer M, Costenbader K, Daikh D, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol 2019; 71(9):1400-1412. <a href="https://onlinelibrary.wiley.com/doi/full/10.1002/art.40930" target="_blank">https://onlinelibrary.wiley.com/doi/full/10.1002/art.40930</a>. Copyright © 2019 American College of Rheumatology. Adapted with permission of John Wiley &amp; Sons Inc. This image has been provided by or is owned by Wiley. Further permission is needed before it can be downloaded to PowerPoint, printed, shared or emailed. Please contact Wiley's permissions department either via email: <a href="/cdn-cgi/l/email-protection#403025322d293333292f2e330037292c25396e232f2d"><span class="__cf_email__" data-cfemail="87f7e2f5eaeef4f4eee8e9f4c7f0eeebe2fea9e4e8ea">[email protected]</span></a> or use the RightsLink service by clicking on the 'Request Permission' link accompanying this article on Wiley Online Library (<a href="https://onlinelibrary.wiley.com/" target="_blank">https://onlinelibrary.wiley.com/</a>).</div><div id="graphicVersion">Graphic 122388 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
